APPLICATION
ANDA065454
TYPE
ANDA
ORIGINAL APPROVAL
2008-07-16
LATEST ACTION
2025-03-31
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription
Products
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 25MG BASE/5ML · FOR SUSPENSION · ORAL
Approval history
2025-03-31Labeling · Supplement 10 · standardAP
2021-07-21Labeling · Supplement 8 · standardAP
2021-07-21Labeling · Supplement 6 · standardAP
2021-07-21Labeling · Supplement 7 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.